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Abstract
Atypical/Nor98 scrapie was first identified in 1998 in Norway. It is now considered as a worldwide disease of small ruminants
and currently represents a significant part of the detected transmissible spongiform encephalopathies (TSE) cases in Europe.
Atypical/Nor98 scrapie cases were reported in ARR/ARR sheep, which are highly resistant to BSE and other small ruminants
TSE agents. The biology and pathogenesis of the Atypical/Nor98 scrapie agent in its natural host is still poorly understood.
However, based on the absence of detectable abnormal PrP in peripheral tissues of affected individuals, human and animal
exposure risk to this specific TSE agent has been considered low. In this study we demonstrate that infectivity can
accumulate, even if no abnormal PrP is detectable, in lymphoid tissues, nerves, and muscles from natural and/or
experimental Atypical/Nor98 scrapie cases. Evidence is provided that, in comparison to other TSE agents, samples
containing Atypical/Nor98 scrapie infectivity could remain PrP
Sc negative. This feature will impact detection of Atypical/
Nor98 scrapie cases in the field, and highlights the need to review current evaluations of the disease prevalence and
potential transmissibility. Finally, an estimate is made of the infectivity loads accumulating in peripheral tissues in both
Atypical/Nor98 and classical scrapie cases that currently enter the food chain. The results obtained indicate that dietary
exposure risk to small ruminants TSE agents may be higher than commonly believed.
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Introduction
Transmissible spongiform encephalopathies (TSE), or prion
diseases, are fatal neurodegenerative disorders occurring in sheep
(scrapie), cattle (bovine spongiform encephalopathy - BSE), or
humans (Creutzfeldt-Jakob disease - CJD). The key event in TSE
is the conversion of a normal cellular protein (PrP
c) into an
abnormal isoform (PrP
Sc) which accumulates in tissues from
infected individuals [1]. PrP
Sc is currently considered to be the
only TSE biochemical marker. According to the prion concept,
abnormal PrP would be the causative agent of TSE [2].
Following the BSE crisis and the identification of its zoonotic
properties [3,4], the control of human and animal exposure to
TSE agents has become a priority. A sanitary policy has been
implemented based on both eradication of TSE in food producing
animals and exclusion of known infectious materials from the food
chain.
In 1998 an Atypical/Nor98 Scrapie was identified in Norwe-
gian sheep; the PrP
Sc signature was partially PK resistant and
displayed a multi-band pattern as showed by Western Blot (WB)
that contrasted with those normally observed in small ruminants
TSE cases [5]. After 2001 and the implementation of active TSE
surveillance plans, a number of similar cases were identified in
most EU members states as well in other countries, like Canada,
USA and New Zealand [6]. The transmissibility of Atypical/
Nor98 agent has been demonstrated in both rodent models
(transgenic animals expressing the ovine Prnp gene) [7] and sheep
[8,9].
Currently Atypical/Nor98 Scrapie represents a significant part
of the TSE cases identified in the EU small ruminant population,
where its prevalence was estimated to range between 5 to 8
positive small ruminants per 10,000 tested per year [10].
Atypical/Nor98 scrapie cases have different biological features
from those observed in other small ruminants TSE [5,6]. Sheep
susceptibility to TSE is strongly controlled by polymorphisms on
the gene (Prnp) encoding for PrP protein [11,12]. The homozygous
and heterozygous ARR sheep are considered to be strongly
resistant to both the classical scrapie [11,12] and the cattle BSE
agents [13]. This resistance has been the basis of a large scale
genetic selection policy aiming at the control of TSE diseases by
increasing the frequency of the ARR allele in general population
and restocking affected flocks with ARR animals. In Atypical/
Nor98 scrapie the sheep genetic susceptibility is significantly
different from what is observed in classical TSE forms, with
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tible to the disease [14,15,16,17,18].
Information about the tissue distribution of Atypical/Nor98
scrapie agent in the host species is limited [5,19,20,21] but
research findings indicate that no detectable abnormal PrP has
been found in peripheral tissues and that the infectious agent could
be restricted to the central nervous system. This key feature led to
consider that dietary exposure risk to Atypical/Nor98 scrapie is
low. The apparent limited spreading of Atypical/Nor98 scrapie in
the organism of affected individuals is also an argument supporting
the hypothesis that this agent has restricted abilities to spread into
the environment or between individuals. PrP
Sc detection generally
correlates with the presence of infectivity [1,22] but infectivity has
been reported in the absence of detectable PK resistant PrP [23].
In this study, we investigate the potential presence of TSE
infectivity in peripheral tissues (lymphoid organs, striated muscles
and nerves) of Atypical/Nor98 scrapie from naturally and
experimentally infected sheep. We then compared the relative
infectivity level present in peripheral tissues with those estimated in
similar tissues from classical scrapie affected sheep.
Results
Atypical/Nor98 scrapie field cases (n=7) collected in three
different countries (Portugal, Norway and France) were investi-
gated for the presence of PrP
Sc and infectivity in lymphoid tissues
and central nervous system (Table 1). These sheep were of various
Prnp genotypes including those associated with high susceptibility
to Atypical/Nor98 scrapie (homozygous or heterozygous
A136F141R154Q171– AHQ) or resistance (homozygous and hetero-
zygous ARR) to classical scrapie or BSE [11,13]. Amongst the
seven cases, five were identified by the active surveillance program
either at rendering plant or slaughter house and two through the
passive surveillance network (clinical suspects). Three of these cases
were identified in fallen stock animals collected in three
independent flocks where an Atypical/Nor98 scrapie case had
previously been identified (Portugal).
In each of these natural Atypical/Nor98 cases, PrP
Sc accumu-
lation could be detected in different brain areas by WB and/or
Immunohistochemistry (IHC). Conversely, no abnormal PrP
deposits were evidenced in any of the investigated lymphoid
organs (Table 1).
Bioassay of brain homogenates prepared from these seven sheep
into transgenic mice that over-express the VRQ allele of ovine PrP
(tg338) [7] were positive for TSE. Surprisingly, despite the absence
of detectable PrP
Sc, the lymphoid tissue homogenates from five out
of the seven cases were positive for TSE in tg338 mice. The attack
rate in mice challenged with lymphoid tissues was lower and the
clinical onset was delayed compared to mice inoculated using CNS
homogenate (Table 1). Brains collected in clinically affected mice
inoculated either with lymphoid tissues or brain homogenates
displayed a similar PrP
Sc WB pattern (Figure 1: lanes 5, 6, 7 –
Figure S2), PrP
Sc deposits distribution and vacuolar lesion profile
(Figure 2A, 2C, 2E- – Figure S2). All these features were identical
to those previously reported in tg338 mice inoculated with a panel
of Norwegian, French [7] and UK [24] Atypical/Nor98 scrapie
isolates. These phenotypic features were clearly different from
those associated to two distinct classical scrapie isolates (Figure 1:
lanes 1–4 and Figure 2B, 2F, 2H). Infectivity was demonstrated in
lymphoid tissues from one out of the two investigated ARR/ARR
Atypical/Nor98 scrapie cases.
Samples collected in two experimental Atypical/Nor98 scrapie
cases were also analyzed; these were from an AHQ/AHQ (case 9)
and an AFRQ/ARQ (case 8) sheep which had been intra-
cerebrally challenged with an AFRQ/AFRQ field Atypical/
Nor98 scrapie isolate (case 1, Figure 1: lane 5). These sheep had
an incubation period of 964 and 2240 days respectively. In both
animals’ CNS, PrP
Sc displayed a WB banding pattern that was
characteristic [14] of Atypical/Nor98 scrapie (Figure 1: lane 6 –
Figure S2). In none of the investigated peripheral tissues PrP
Sc
could be detected (Table 2). In the tg338 bioassay, infectivity was
shown in some but not all tested lymphoid tissues, and in striated
muscle and peripheral nerves from both cases (Table 2 – Figure 1:
lanes 8–9 – Figure S2). Incubation periods were prolonged in
comparison to brain homogenates and the attack rate was lower
than 100%. The phenotypes of the propagated prions in tg338
mice (WB banding pattern, vacuolar lesion profile and PET Blot
PrP
Sc distribution in brain) were identical to the one observed with
natural Atypical/Nor98 scrapie isolates (Figure 1: lanes 5, 7, 9-
Figure 2C, 2E, 2G).
A similar experiment was performed using peripheral and CNS
tissues from natural or experimental classical scrapie cases at
clinical stage of the disease. This study involved two distinct
classical scrapie agents (Langlade and PG127), which can be
distinguished on the basis of their lesion profile in tg338 mice
(Figure 2F). The inoculation of peripheral tissues homogenates
from animals infected with those classical scrapie agents into tg338
resulted in a 100% attack rate transmission, but with prolonged
incubation period by comparison to mice inoculated with CNS
samples (Table 2). For both isolates, PrP
Sc WB banding pattern
(Figure 1: lanes 1–4 – Figure S2), vacuolar lesion (Figure 3F, 3H –
Figure S2) observed in mice inoculated with CNS and peripheral
tissues were identical. As previously described and conversely to
Atypical/Nor98 scrapie, PrP
Sc could be detected in the investi-
gated lymphoid organs, and striated muscle [25,26,27,28] from all
the four classical scrapie affected animals involved in this study
(Table 2).
In order to determine the cause of our incapacity to detect
abnormal PrP in the peripheral tissues of Atypical/Nor98 scrapie
cases that contain infectivity, classical scrapie (cases 10 and 12) and
Atypical/Nor98 scrapie (cases 1, 8, 9) brain homogenates dilution
Author Summary
Following the bovine spongiform encephalopathy (BSE)
crisis and the identification of its zoonotic properties, a
sanitary policy has been implemented based on both
eradication of transmissible spongiform encephalopathies
(TSE) in food-producing animals and exclusion of known
infectious materials from the food chain. Atypical/Nor98
scrapie is a prion disease of small ruminants identified
worldwide. Currently it represents a significant part of the
TSE cases detected in Europe. The restricted tissue
distribution of Atypical/Nor98 scrapie agent in its natural
host and the low detected prevalence of secondary cases
in affected flocks meant that it is believed to be a poorly
transmissible disease. This has led to the view that
Atypical/Nor98 scrapie is a spontaneous disorder for which
human and animal exposure risk remains low. In this study
we demonstrate that in affected individuals, Atypical/
Nor98 scrapie agent can disseminate in lymphoid tissues,
nerves, and muscles, challenging the idea that it is a brain-
restricted infectious agent. Evidence for the deficiencies in
the current methods applied for monitoring Atypical/
Nor98 scrapie is provided that would indicate an
underestimation in the prevalence in the general popula-
tion and in the affected flocks. These elements challenge
the hypothesis on the biology of this recently identified
TSE agent.
Atypical/Nor98 Scrapie Detection
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Sc
detection WB (TeSeE WB Kit – BIORAD), a PrP
Sc ELISA
detection assay (TeSeE Sheep and Goat
- BIORAD) (Figure 3 and
Figure S1) and bioassays in tg338 mice (Table 3).
According to the endpoint titration, the infectious titre in the
Langlade and PG127 classical scrapie isolates were estimated to be
respectively 10
6.8 ID50 IC tg338 per gram and 10
6.6 ID50 IC tg338
per gram (Table 3- Figure 4A). All the titrated Atypical/Nor98
scrapie cases (n=5, see Table 3) that we investigated displayed
substantially higher infectious titres, ranging between 10
8.7 and
10
9.5 ID50 IC tg338/g (Table 3-Figure 4 B).
For the two classical scrapie isolates, WB detected PrP
Sc to a
dilution of 10
3 (positive detection on 25 mg of brain equivalent
material) which corresponded to 10
2.2 (Langlade isolate) and 10
2
(PG127 isolate) ID50 IC tg338 (Figure 3). For the AHQ/AHQ
Atypical/Nor98 scrapie isolate (case 9), PrP
Sc WB detection limit
was the 1/80 dilution (312 mg of brain starting material)
(Figure 3A) which corresponded to 10
6 IC ID50 in tg338
(Figure 4E). Similar results were obtained with the two other
atypical scrapie isolates (cases 1 and 8) for which the detection
limits of PrP
Sc assays were respectively equivalent to 10
5.6 and
10
5.5 ID50 IC tg338 (Table 3 and Figure S1). These results indicate
that PrP
Sc detection assays currently used for field TSE testing
could have a dramatically lower intrinsic sensitivity for identifying
Atypical/Nor98 scrapie agent than classical scrapie agent.
As previously described [29,30,31,32,33,34], the end point
infectivity titration data that was generated with the two different
types of classical scrapie agents (case 10 and case 12) and the
Atypical/Nor98 scrapie cases (cases 14 and 15) were used to fit the
best logistic regression models correlating the incubation periods in
tg338 mice with the infectious dose (Figure 4). These models were
then applied to estimate the infectious content in the different
tissues using the incubation periods in tg338 mice (Tables 1 and 2).
By this approach, the infectious titre of three atypical scrapie
samples (cases 1: cerebral cortex - case 8: cerebellum – case 9:
cerebral cortex) were estimated respectively 10
8.7,1 0
8.7, and 10
8.3
ID50 IC tg338/gram (Tables 1 and 2). The measured infectious
titre in the same three samples, by endpoint titration in tg338, were
respectively 10
9.1,1 0
8.7 and 10
9.5 ID50 IC tg338/gram (Table 3).
In the investigated Atypical/Nor98 scrapie cases, the infectious
load in muscle and lymphoid tissues samples from sheep affected
were close to the sensitivity of our bioassay (10
2,7 ID50 IC per gram
of tissue); ie about 10
6 fold lower than the infectivity level
measured (by endpoint titration) or estimated (on the basis of the
incubation periods) in the same amount of brain prepared from
clinically affected sheep (Tables 1 and 2).
Table 1. Abnormal PrP (PrP
Sc) and infectivity in central nervous system and lympho-reticular system of natural Atypical/Nor98
scrapie incubating or affected animals bearing various genotypes at codons 136, 141, 154 and 171 of the Prnp gene.
PrP
Sc tg338 transmission
Case Genotype Origin Age Category Tissues WB ELISA IHC
Positive
mice
Incubation
period in days
(mean +/2SD)*
Estimated
infectious titre(IC
ID50 in tg338/g)
1 AFRQ/AFRQ FR 6 years clinical Cerebral cortex pos pos pos 6/6 209+/212 10
8.7
Brainstem neg neg pos
++ 6/6 256+/214 10
5.5
Prescapular LN neg neg neg 3/5 334+/210 ND
2 ALRQ/ARR PT 6 years fallen stock
(additional case)
Cortex pos pos pos 6/6 231+/217 10
6.7
Retropharyngeal LN
+ neg neg ND 5/6 349+/276 ND
3 ARR/ARR PT 8 years fallen stock
(additional case)
Cerebral cortex pos pos pos 6/6 221+/219 10
6.7
Retropharyngeal LN
+ neg neg ND 4/6 348+237 ND
4 AFRQ/VRQ PT 9 years fallen stock
(additional case)
Cerebral cortex
+ pos pos pos 6/6 239+/228 10
6
Retropharyngeal LN
+ neg neg ND 0/6 .650
5 AHQ/AHQ NO 3,5 years clinical Cerebellum pos pos pos 5/5 224+/221 10
6.7
Parotideal LN neg neg neg 2/2 285–298* 10
4.4
6 AHQ/AHQ NO 7,5 years slaughter Cerebellum pos pos pos 5/5 248+/215 10
5.8
Popliteal LN neg neg neg 1/10 401* ND
7 ARR/ARR NO 7 years slaughter Cerebellum pos pos pos 5/5 279+/246 10
5.8
Thoracic spinal cord neg neg neg 5/5 346+/285 10
2.9
Prescapular LN neg neg neg 0/6 .650
Two different methods were applied to detect PrP
Sc presence in tissue homogenate that were used for mice inoculation: WB (TeSeE WB kit – BioRad, using SHa31 as
anti-PrP antibody) and ELISA (TeSeE Sheep and Goat– BioRad). Additionally when formalin fixed tissue was available, PrP
Sc immunohistochemistry was also carried out
(using 8G8 antibody). (
++) indicate a case were minimal PrP
Sc labelling was observed after the exam of a serial series of slides. In some cases (
+), the tissue homogenates
were heated (60uC 210 min) in order to destroy contaminating bacteria before bioassay. Such heat treatment might have reduced infectivity level in these samples in
an unknown proportion. Mice were considered positive when abnormal PrP deposition was detected in brain. Incubation periods are presented as mean +/2SD (in
days) except for that dilution with which less than 50% of mice were found positive. In that case (
*) incubation periods of the positive mice are individually presented. In
the different tissues, infectious titres were estimated on the basis of incubation period in mice (Figure 4). This estimation was only performed when the attack rate was
100% and data from more than 5 animals were available.
ND: not done.
doi:10.1371/journal.ppat.1001285.t001
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incubation period recorded in tg338 inoculated with lymphoid
tissues and striated muscle were consistent with infectious titre
about 10 fold lower than the one measured in brains from those
terminally affected animals (Table 2).
Discussion
Bioassay endpoint titration is considered as the most accurate
method for determining the TSE infectivity titre in tissues.
Although regarded as less accurate, dose-response relationships
have been used as a method for infectivity estimation when
endpoint titration data are not available; in such an approach, the
incubation period observed in the inoculated mice is used
to estimate the infectious titre of the samples tested
[29,30,31,32,33,34]. In this study, the dose-response approach
was used to estimate the infectious titre in various peripheral
tissues from Atypical scrapie/Nor98 and classical scrapie affected
sheep. For mice inoculated with peripheral tissue homogenates,
the standard curve established using reference CNS homogenates
was used, but it was established that the lesion profile was identical
in the mice inoculated with the peripheral tissue and the CNS.
Although it could be hypothesized that the nature of the peripheral
tissue inoculated would impact on the observed incubation length
in mice (matrix effect) and consequently on the estimated
infectious titre, Dickinson et al. [29,30] demonstrated that in
conventional mice the dose-response obtained with the spleen and
the brain from ME7 infected mice are similar.
Together these elements indicate, that even if the peripheral
tissues infectious titre reported are ‘estimates’, they provide a good
guide to the relative infectivity levels that are present in the
Atypical scrapie/Nor98 and classical scrapie cases’ brain and
peripheral tissues.
The presence of PrP
Sc and infectivity in small ruminant’s
peripheral tissues affected with natural classical scrapie or
experimental BSE is well established [25,27,35,36,37]. It is
generally considered that peripheral tissues like lymphoid tissues
and striated muscle contain much lower levels of prion than CNS
from terminally affected animals. This concept is the basis of the
statutory measures aiming at limiting the entry of small ruminants
TSE agents into the food chain. Tissues considered to be the most
infectious (named Specific Risk Material) are systematically
discarded from consumption, but tissues that would potentially
contain only a low level of infectivity might enter the food chain
due to the feasibility/practicality of removing them.
In this study, the estimated infectivity level in skeletal muscle
and lymphoid tissues from animals (n=4) affected with two
different classical scrapie isolates did reach up to 1/10 (weight/
weight) of the infectivity found in the CNS from terminally
affected sheep. These values are higher than those expected from
previous work. This could be explained by the fact that previously
available data on prion quantities in peripheral tissues of small
ruminants (in particular those related to striated muscle) relied on
biochemical measurement of PrP
Sc amount [26] and the cell types
accumulating PrP
Sc and the composition of these tissues may have
impact on the PrP
Sc recovery yield. Also, if in some classical
scrapie cases a 3–4 log10 infectivity difference was reported
between CNS and some lymphoid tissues using bioassay in
conventional mice, in other classical scrapie cases, the same study
reported that infectivity in lymphoid tissue was only 1 to 10 fold
lower than in CNS [27].
The classical scrapie cases that were investigated in this work
cannot be assumed to be representative of all field diversity as only
four animal cases of highly susceptible genotypes were used.
However, the results indicate that exposure risk to such TSE
agents through the unrestricted entry in the food chain of
potentially infectious tissues would be significantly higher than
previously thought.
In most countries, the identification of Atypical/Nor98 scrapie
was a consequence of the implementation of an active surveillance
for TSE consisting in random testing for PrP
Sc presence in
brainstem of a fraction of fallen or healthy culled small ruminants
Figure 1. PrP
Sc Western Blot detection in sheep and tg338 mice inoculated with Atypical/Nor98 scrapie and classical scrapie tissues
(10% tissue homogenate). Lane 1: posterior brainstem from a Langlade classical scrapie affected sheep (case 10). Lane 2: brain from a tg338
mouse inoculated with striated muscle (semi-membranous) from the same sheep (case 10). Lane 3: posterior brainstem from a PG127 classical
scrapie orally inoculated sheep (case 12). Lane 4: brain from a tg338 mouse inoculated with striated muscle (extra-ocular motor muscle) from the
same PG127 classical scrapie affected sheep (case 12). Lane 5: cerebral cortex from an AFRQ/AFRQ Atypical/Nor98 scrapie natural case (case 1). Lane
6: AHQ/AHQ sheep (cerebellum-case 9) intra-cerebrally challenged with natural atypical scrapie (case 1). Lane 7 to 9: brain homogenates from tg338
mice inoculated with peripheral tissues from atypical scrapie cases. Lane 7: retropharyngeal lymph node (case 2). Lane 8: sciatic nerve (case 9). Lane
9: striated muscle (case 8). No PrP
Sc was observed in control tg338 mice inoculated with retropharyngeal LN from a negative control sheep (Lane 10).
doi:10.1371/journal.ppat.1001285.g001
Atypical/Nor98 Scrapie Detection
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detection tests that are used for initial field screening or
confirmation of TSE cases is debated. Several authors reported
failure to detect PrP
Sc in some CNS areas like the obex area
[5,6,20] from known affected animals or discrepancies in results
when applying different diagnostic tests to a same sample [6,10].
The results obtained in this study by comparing the analytical
sensitivity of biochemical PrP
Sc detection (using an OIE registered
WB method and a validated rapid screening test for TSE
detection, in small ruminants) and bioassay indicated that CNS
samples that would contain up to 10
7.4.–10
7.7 ID50/g of Atypical/
Nor98 scrapie (according to tg338 IC bioassay) could remain
negative for PrP
Sc detection. In field, Atypical/Nor98 scrapie cases
(Table 1) PrP
Sc positive WB was observed in CNS samples in
which infectious titre was estimated (on the basis of incubation
period) to be higher than 10
5.8 ID50/g IC in tg338. Such
discrepancies might reflect an individual variability of the PrP
Sc
WB detection limits between atypical scrapie cases. It might
alternatively be the consequence of a relative imprecision in
estimating the titre of low infectious doses by the incubation period
bioassay method.
In contrast to Atypical/Nor98 scrapie cases, using two different
classical agents the WB PrP
Sc detection sensitivity limit was about
10
2 ID50 IC in tg338 (ie a tissue with a titre of 10
3.7 ID50/g IC in
tg338). These differences strongly support the contention that
diagnostic assays based on PrP
Sc detection have lower perfor-
mance for identifying Atypical/Nor98 scrapie cases than classical
scrapie cases. It is consequently highly probable that a significant
number of Atypical/Nor98 cases remain undetected by field
testing, leading to an underestimation of Atypical/Nor98 scrapie
prevalence in the small ruminant population. It is however not
possible on the sole basis of this study to evaluate the importance
of such underestimation.
The under detection of Atypical/Nor98 scrapie in the field due
to the sensitivity of the current PrP
Sc based approach would also
impact on understanding of the biology of this TSE agent.
While under natural conditions, classical scrapie is known to
transmit between individuals, the analysis of data collected
through the active TSE surveillance program seemed to indicate
that Atypical/Nor98 scrapie could be poorly or not transmissible
at all. This is based on the lack of statistical difference of the
observed Atypical/Nor98 frequencies between the general popu-
lation and the flocks where a positive case had been identified
[38,39]. The lower ability to detect Atypical Scrapie incubating
animals using the PrP
Sc based methodologies means that this
conclusion should be considered with caution.
Atypical/Nor98 cases are identified in older animals in
comparison to classical scrapie [6,40]. The lack of PrP
Sc detection
in peripheral tissues of reported cases suggested that Atypical/
Nor98 scrapie agent could be restricted to CNS. This is supportive
of the hypothesis that Atypical/Nor98 scrapie could be a
spontaneous disorder of PrP folding and metabolism occurring
in aged animals without external cause [6,38].
However, this hypothesis is questioned by the evidence reported
here that a negative PrP
Sc testing result could be observed in
animals harbouring high infectious titre in their brain and that the
infectious agent can be present in peripheral tissues of Atypical/
Nor98 scrapie incubating sheep. TSE are considered to be
transmitted following oral exposure; initial uptake is followed by a
peripheral replication phase which is generally associated with a
dissemination of the agent in the lymphoid system and the
deposition of large amounts of PrP
Sc. This peripheral replication
phase is later followed by the entry of the infectious agent into the
CNS through the autonomic nervous system [25,27,35,36].
However, in several situations, like BSE in cattle [41,42,43] or
classical scrapie in ARR heterozygote sheep [44,45], the
involvement of secondary lymphoid system is marginal, which
does not preclude central neuro-invasion through the autonomic
nervous system [46]. It could be proposed that Atypical Scrapie/
Nor98 might occur following oral exposure to a TSE agent, which
would spread marginally in lymphoid tissues before neuro-
invasion. The slow propagation of Atypical Scrapie/Nor98 in its
host (long incubation period) and the impaired detection sensitivity
level of PrP
Sc based assays would explain the apparent old age of
detected cases.
The results presented here are insufficient to rule out the
hypothesis of a spontaneous/non contagious disorder or to
consider this alternative scenario as a plausible hypothesis. Indeed,
the presence of Atypical scrapie/Nor98 infectivity in peripheral
tissues could be alternatively due to the centripetal spreading of the
agent from the CNS. However, our findings point out that further
clarifications on Atypical/Nor98 scrapie agent biology are needed
before accepting that this TSE is a spontaneous and non
contagious disorder of small ruminants. Assessing Atypical/
Nor98 scrapie transmissibility through oral route in natural host
and presence in placenta and in colostrum/milk (which are
considered as major sources for TSE transmission between small
ruminants) [28,32] will provide crucial data.
The presence of infectivity in peripheral tissues that enter the
food chain clearly indicates that the risk of dietary exposure to
Atypical/Nor98 scrapie cannot be disregarded. However, accord-
ing to our observations, in comparison to the brain, the infectious
titres in the peripheral tissues were five log10 lower in Atypical/
Nor98 scrapie than in classical scrapie. Therefore, the reduction of
the relative exposure risk following SRM removal (CNS, head,
spleen and ileum) is probably significantly higher in Atypical/
Nor98 scrapie cases than in classical scrapie cases. However,
considering the currently estimated prevalence of Atypical/Nor98
scrapie in healthy slaughtered EU population [10], it is probable
that atypical scrapie infectivity enters in the food chain despite the
prevention measures in force.
Finally, the capacity of Atypical/Nor98 scrapie agent (and more
generally of small ruminants TSE agents) to cross species barrier
that naturally limits the transmission risk is insufficiently
documented. Recently, the transmission of an Atypical/Nor98
scrapie isolate was reported into transgenic mice over-expressing
the porcine PrP [47]. Such results cannot directly be extrapolated
to natural exposure conditions and natural hosts. However, they
underline the urgent need for further investigations on the
Figure 2. PrP
Sc distribution pattern and lesion profile in tg338 mice inoculated with Atypical/Nor98 scrapie and classical scrapie
sheep tissues. (A–D) PET Blot (SHa31 antibody – NBT/BCIP black deposits- bar: 200 mm) of brain coronal section (thalamus level) from tg338
inoculated with (A) AHQ/AHQ atypical scrapie cerebellum (case 9), (B) posterior brainstem from VRQ/VRQ classical scrapie (PG127- case 12), (C)
retropharyngeal lymph node from a ARR/ARR natural atypical case at preclinical stage of the disease (case 3), (D) striated muscle from a AFRQ/ARQ
experimental atypical case (case 8) at clinical stage of the disease. (E–H) Lesion profile (vacuolar changes) in tg338 mice inoculated with: (E) Natural
(case 3 - n) and experimental (case 9-N) cerebral cortex from atypical scrapie cases, (F) Langlade (case 10-,) and PG127 (case 12-N) VRQ/VRQ
posterior brainstem homogenates, (G) brachial nerve from an AFRQ/ARQ experimental atypical case (case 8-X) and AFRQ/AFRQ natural atypical case
(case 1-,), (H) striated muscle from Langlade (case 10- ,- semi-membranous) and PG127 (case 12-N-psoas) classical scrapie affected sheep.
doi:10.1371/journal.ppat.1001285.g002
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PLoS Pathogens | www.plospathogens.org 6 February 2011 | Volume 7 | Issue 2 | e1001285potential capacity of Atypical/Nor98 scrapie to propagate in other
species than small ruminants.
Methods
Ethics statement
All animal experiments were performed in compliance with our
institutional and national guidelines, in accordance with the
European Community Council Directive 86/609/EEC. The
experimental protocols were approved by the INRA Toulouse/
ENVT and by the Norwegian ethics committees.
Atypical/Nor98 and classical scrapie natural cases
The natural classical scrapie case (case 10) included in this
experiment was a Romanov sheep born and bred in the Langlade
flock where a natural scrapie epidemic has been occurring at a high
incidence since 1993 [11].
Table 2. PrP
Sc and infectivity in tissues from experimental (IC challenged) Atypical/Nor98 scrapie cases and natural or
experimental (oral or intra-cerebral challenge) classical scrapie cases.
PrP
SC Bioassay results
TSE isolate Case Case origin Genotype Tissue ELISA WB IHC
Positive
mice
Incubation
period in days
(mean +/2SD)
Estimated
infectious titre
(ID50 IC in tg338/g)
Atypical/
Nor98
scrapie
8 Experimental
intracerebral
AFRQ/ARQ Cerebellum pos pos pos 6/6 204+/251 0
8.7
Ileal LN neg neg neg 0/6 -
Prescapular LN neg neg neg 1/5 445* ND
Brachial nerve neg neg neg 3/5 369+/220 ND
External ocular
muscle
neg neg neg 5/6 409+/266 ND
9 Experimental
intracerebral
AHQ/AHQ Cerebral cortex pos pos pos 6/6 219+/241 0
8.3
Ileal LN neg neg neg 0/6 -
Sciatic nerve neg neg neg 3/6 516+/2133 ND
External ocular
muscle
neg neg neg 2/6 370–450* ND
Langlade Classical
scrapie
10 Natural VRQ/VRQ Posterior brain
stem
pos pos pos 6/6 221+/220 10
6.8
Spleen pos ND pos 6/6 431+/232 10
5.5
Ileal LN pos ND pos 6/6 436+/266 10
5.5
External ocular
muscle
pos neg pos 6/6 427+/229 10
5.6
Semi membranous
muscle
pos neg pos 6/6 481+/246 10
5.4
11 Experimental
intracerebral
VRQ/VRQ Posterior brain
stem
pos pos pos 6/6 229+/214 10
6.8
Psoas muscle pos neg pos 6/6 389+/263 10
5.8
PG 127
Classical
scrapie
12 Experimental
oral
VRQ/VRQ Posterior brain
stem
pos pos pos 6/6 64+/241 0
6.6
Ileal LN pos ND pos 6/6 78+/231 0
5.5
External ocular
muscle
pos ND pos 6/6 81+/221 0
5.1
Psoas muscle pos ND pos 6/6 87+/271 0
4.5
13 Experimental
intracerebral
VRQ/VRQ Posterior brain
stem
pos pos pos 6/6 61+/21 $10
6.6
Tonsil pos ND pos 6/6 79+/211 0
5.4
External ocular
muscle
pos ND pos 6/6 77+/221 0
5.5
Animals were sampled at clinical stage of the disease. Mice were considered positive when abnormal PrP deposition was detected in brain. Incubation periods are
presented as mean +/2SD except for that dilution with which less than 50% of mice were found positive. In that case (*) incubation periods of the positive mice are
individually presented. ND: not done.
Two different methods were applied to detect PrP
Sc presence in tissue homogenate that were used for mice inoculation: WB (TeSeE WB kit – BioRad, using SHa31 as
anti-PrP antibody) and ELISA (TeSeE Sheep and Goat– BioRad). Additionally when formalin fixed tissue was available PrP
Sc immunohistochemistry was also carried out
(using 8G8 antibody). Infectious titres in the different tissues were estimated on the basis of incubation period in mice (Figure 4). This calculation was only performed
when the attack rate was 100% and data from more than 5 animals were available.
doi:10.1371/journal.ppat.1001285.t002
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PLoS Pathogens | www.plospathogens.org 7 February 2011 | Volume 7 | Issue 2 | e1001285Figure 3. PrP
Sc detection limit of a Langlade classical scrapie isolate, a PG127 classical scrapie isolate and an Atypical/Nor98 scrapie
isolate. Dilution series from (A, D) Atypical/Nor98 scrapie isolate (case 9- cerebral cortex), (B) Langlade–case 10- posterior brainstem) and (C) PG127
(case 12- posterior brainstem) classical scrapie isolate, that were prepared in negative sheep brain homogenate. The tissue homogenates (see
methods) are the same than the one used for endpoint titration in tg338 mice (Table 3). The samples were processed for PrP
Sc Western-blotting (A–C,
TeSeE WB kit – BioRad, anti-PrP SHa31 antibody). After extraction (25 mg of brain equivalent material), the re-suspended pellet was either entirely
loaded on lanes (A: all lanes – B and C: Lanes 4–6) or diluted in Laemmli’s buffer before loading (B: lane 3, 1/50 – Lane 4, 1/10 – C: lane 3, 1/20). These
dilutions were necessary to avoid a saturation of the signal. A classical scrapie control was included on the three gels to calibrate the signal (Lane 1).
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PLoS Pathogens | www.plospathogens.org 8 February 2011 | Volume 7 | Issue 2 | e1001285Natural atypical scrapie cases were identified though active or
passive surveillance programs in France, Norway and Portugal
(Table 1). The Portuguese cases were identified in three
independent flocks where an atypical case had already been
identified in the past (additional cases). In all cases, PrP genotype
was obtained by sequencing the Exon 3 of the Prnp gene as
previously described [14]. In each case, the polymorphisms at
codons 136 (A/V), 154 (H/R) and 171 (R/Q), which have been
demonstrated to strongly influence the susceptibility to TSE in
sheep are indicated [48]. Additionally the presence of a
phenylalanine at codon 141 (F/L), which has been shown to
impact on the susceptibility to atypical/Nor98 scrapie, was
indicated [14,49].
Atypical/Nor98 scrapie and classical scrapie experimental
cases
Two sheep (one 12 months old AFRQ/ARQ (case 8) and one
14 months old AHQ/AHQ (case 9)) selected in a field flock were
IC challenged with French AFRQ/AFRQ Atypical Scrapie (case
1) (Table 2). The animals were euthanized when showing clear
clinical signs at respectively 2224 and 964 days post inoculation.
TSE-free Poll-Dorset sheep (VLA- Weybridge- UK) were used
for intracerebral inoculation with Langlade isolate (case 10,
inoculum derived from a VRQ/VRQ natural isolate), or PG127
isolate (inoculum derived from a VRQ/VRQ experimental case).
Animals were killed when displaying evident clinical signs at
respectively 380 days and 160 days post inoculation. Oral
challenge was performed in 6–10 months old TSE-free New
Zealand cheviot sheep. Animals were dosed with 5 g equivalent of
brain material (1% brain homogenate in glucose) derived from an
experimentally VRQ/VRQ affected sheep (PG127 isolate).
Animals were culled at clinical stage of the disease (200 days post
inoculation).
Tissue samples collection, homogenate preparation
All tissues were collected using disposable equipment (forceps
and scalpels). The different field and experimental cases were
sampled on different dates and/or places. Different instrument sets
and containers were used for collecting, transporting and storing
each sample. Finally, in all cases, peripheral tissues were collected
before CNS to further reduce the risk of cross contamination. In
natural Atypical/Nor98 cases, the nature of the tissues collected
under TSE sterile conditions might have varied according to the
country and date of collection. In all cases, CNS and at least one
lymph node were available. In both Atypical/Nor98 and classical
scrapie experimental cases, a large panel of tissues (including
Central Nervous System, Peripheral Nervous System, digestive
tract wall, muscle) was collected under TSE sterile conditions.
From the available samples, tissues homogenates (20% stock
material) were prepared in Norway (Norwegian cases) or in France
(French natural and experimental cases and Portuguese cases).
The list of processed samples is given in Tables 1 and 2. In each
case disposable equipment was used to manipulate the tissues.
20% tissues homogenates were prepared using single use grinding
microtubes (Precess 48 - BioRad) and filtered through a 25 gauge
needle (single use syringe). The tissue homogenates were then
aliquoted (in 2 ml and 5 ml tubes) and stored at 280uC.
Peripheral tissues homogenates and CNS homogenates were
prepared separately.
Tissue processing and immunohistochemistry (IHC)
detection
This method was performed as previously described [50]. PrP
Sc
IHC detection was first performed using 8G8 antibody raised
against human recombinant PrP protein and specifically recog-
nising the 95–108 amino acid sequence (SQWNKP) of the PrP
protein.
For each sample a negative serum control was included, in
which the primary antibody was either omitted or replaced by
purified mouse IgG2a serum.
PrP
Sc Western-blot detection (WB)
An OIE registered Western blot kit (TeSeE Western Blot,
BioRad) was used following the manufacturer’s recommendations.
For each sample, 250 ml of 10% brain homogenate were
submitted to PrP
Sc extraction. The obtained pellet was denatu-
rated in Laemmli’s buffer (15 ml) before being loaded neat or
diluted (Figure 4) on a 12% acrylamide gel, and submitted to
electrophoresis and blotting. Immunodetection was performed
using SHa31 which recognizes the 145–152 sequence of PrP
(YEDRYYRE). Peroxidase activity was revealed using ECL
substrate (Pierce) [26].
ELISA PrP
Sc detection
A commercially available TSE detection test (TeSeE Sheep and
Goat - BioRad) was used according to manufacturer’s recommen-
dations. In summary, five hundred mL of the 20% homogenate
were incubated for 10 min at 37uC with 500 mL of buffer A
containing proteinase K. PrP
sc was recovered as a pellet after
addition of 500 mL of buffer B and centrifugation for 5 min at 20
000 g at room temperature. Supernatant was discarded and tubes
dried. Finally, the pellet was denatured in buffer C (5 min at
100uC) and 1:6 diluted in R6 reagent before distribution into the
wells [28,51].
Paraffin-embedded tissue blot (PET blot)
PET blots were performed using a method previously described
[52,53]. Immunodetection was carried out using SHa31 mono-
clonal antibody (4 mg/mL), followed by application of an alkaline
phosphatase labeled secondary antibody (Dako reference D0314 –
1/500 diluted). Enzymatic activity was revealed using NBT/BCIP
substrate chromogen.
Bioassay
Bioassay experiments were carried out in ovine VRQ PrP
transgenic mice (tg338), which are considered to be highly efficient
for the detection of sheep scrapie infectivity [54]. At least six mice
were intra-cerebrally inoculated with each sample (20 mL).
Prior to inoculation, homogenates were diluted (final
concentration 10% or 12.5%) in 5% glucose sterile solution.
Each homogenate was then tested for bacteria presence (blood
gelose overnight 37uC culture) and non sterile homogenates
were submitted to a heat treatment (60uC–1 0 m i n ) .H e a t
treated samples are identified in Table 1. The impact of such
(D) The atypical/Nor98 scrapie isolate dilution serie (case 9: cerebral cortex) was tested using a commercially available rapid TSE test (TeSeE Sheep
and Goat - BioRad) used for field TSE screening in small ruminants. Three different aliquots of each dilution were independently tested. The
extractions were carried out. Results are presented as the mean +/2 SD corrected optical density values. The cut off value (0.162 OD– dotted lines)
was established as the mean of four negative control optical densities + 0.150 OD.
doi:10.1371/journal.ppat.1001285.g003
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PLoS Pathogens | www.plospathogens.org 10 February 2011 | Volume 7 | Issue 2 | e1001285Figure 4. Infectivity titre in reference brain sample from classical and Atypical/Nor98 affected ewes. (A–B) Intra-cerebral endpoint
titration in a tg338 mouse model of CNS homogenate (20 ml per mice), (A) prepared from terminally scrapie affected sheep with Langlade isolate
(12.5% homogenate - case 10 - #) and with PG127 isolate (10% homogenate- case 13- n)–( B) an ARQ/ARQ (10% homogenate - case 14- #) and an
ARR/ARR (10% homogenate -case 15- n) atypical scrapie cases identified in field through active epidemiosurveillance program. Such titration allowed
the determination of the infectious dose 50 (ID50) of the reference brain samples (Table 3). (D–E) Variation of the incubation period as a function of
the infectious dose inoculated intra-cerebrally in tg338 mice. (C): Langlade isolate, (D): PG127 isolate and (E): atypical scrapie isolate. To establish
these diagrams, the individual incubation periods and the number of ID50 inoculated in each mouse were plotted. The number of ID50 is obtained by
multiplying the titre of the inoculum (ID50 IC in tg338 per gram of tissue) per the amount of tissue inoculated in each mice. On this basis, a four
parameter logistic regression was computed (Sigma Plot) to provide a curve associating the incubation period and the number of ID50 inoculated
with the observed incubation period.
doi:10.1371/journal.ppat.1001285.g004
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Portuguese and French cases’ inoculations were carried out in
UMR INRA ENVT 1225 (Toulouse, France) facilities while
Norwegian cases were inoculated at the NVI (Oslo, Norway).
Peripheral tissues and CNS homogenates were inoculated on
different days in order to avoid any risk of cross contamination. In
some cases, tissues autolysis resulted in the death of some animals
inoculated which explain the low number of mice for some
isolates. Mice were monitored daily until the occurrence clinical
signs of TSE. Mice were culled when they started to show
locomotor disorders and any impairment in their capacity to feed.
CNS samples were individually collected. A part of the brain
(cerebral cortex) was frozen for PrP
Sc Western blot testing (TeSeE
WB kit- BioRad) and the other part of the brain was formalin fixed
for vacuolar brain lesion profiling [55] and PrP
Sc PET-Blotting.
Reference Central Nervous System samples end point
titration
Five different isolates were endpoint titrated in tg338 mice, by
inoculating intra-cerebrally (20 ml) successive 1/10 dilutions of
CNS homogenate in groups of tg338 mice (6 or 12 mice). The
material used for the titration was 10% brain homogenate except
for the Langlade isolate (12.5% homogenate).
Two classical scrapie inocula used for sheep inoculation
(Langlade: case 10, posterior brain stem - PG127: case 12,
posterior brain stem) were titrated in UMR INRA ENVT 1225.
The titration of the Langlade material was already published in a
previous study [32].
Two confirmed atypical scrapie isolates (one from an ARQ/
ARQ Norwegian sheep: case 14, cerebellum and one from a
French ARR/ARR sheep: case 15, cerebellum) were titrated in
INRA Jouy-en-Josas. These isolates correspond to two atypical
cases originally described in the Le Dur et al. study in which they
were respectively identified as Lindos and DS8 [7].
Three additional atypical scrapie isolates (AFRQ/AFRQ: case
1, cerebral cortex- AHQ/AHQ: case 9, cerebral cortex– AFRQ/
ARQ: case 8, cerebellum) were titrated in UMR INRA ENVT
1225.
The infectious titre (Infectious Dose 50) of the brain
homogenates was determined by the Spearman-Ka ¨rber’s method
[56].
Estimation of infectious titre on the basis of incubation
period
For each isolate, the incubation periods recorded in individual
tg338 and the number of ID50 inoculated to each mice (number of
ID50 per 20 mL of the inoculated homogenate) (derived from
Table 3) were plotted on a graph. On the basis of this data a four
parameter logistic regression function was computed (Sigmaplot).
This function was then used to estimate the infectious titre
(number of Infectious Dose 50) contained in tissue samples on the
basis of the incubation period observed in tg338 mice
[29,30,31,32,33,34].
PrP
Sc versus bioassay analytical sensitivity
CNS homogenate dilutions series from three different Atypical/
Nor98 scrapie cases (case 1: cerebral cortex – case 8: cerebellum –
case 9: cerebral cortex) were prepared by successive dilutions in
negative brain homogenate.
The prepared dilutions were: 1/2, 1/5, 1/10, 1/20, 1/40, 1/80,
1/100, 1/200, 1/400, 1/800, 10
23,1 0
24,1 0
25,1 0
26,1 0
27,
10
28. The dilutions series were tested for PrP
Sc using TeSeE
Sheep and Goat ELISA test and the WB as previously described in
the text.
The neat sample and 10
25 to 10
27 dilutions from the same
series were inoculated in groups of 6 tg338 in order to assess the
infectious titre (see paragraph: Reference Central Nervous System
samples endpoint titration).
Dilutions series of CNS homogenates were prepared from the
Langlade scrapie (case 10: posterior brainstem) and PG127 (case
12: posterior brainstem) homogenates that were endpoint titrated
in tg338 mice (Table 3). For these dilutions an aliquot of the 20%
stock homogenate (stored at 280uC) was used as starting material.
The dilution series (neat, 10
21,1 0
22,1 0
23,1 0
24,1 0
25,1 0
26,
10
27) were then tested by WB (TeSeE WB kit – BioRad).
Supporting Information
Figure S1 PrP
Sc detection limit in Atypical/Nor98 scrapie
isolates. Dilution series from two atypical Atypical/Nor98 scrapie
isolates (case 1: cerebral cortex, and case 8: cerebellum) were
prepared in negative sheep brain homogenate. The tissue
homogenates (see methods) are the same than those used for
endpoint titration in tg338 mice (Table 3). (A–B) The samples were
processed for PrP
Sc using an OIE registered Western-blotting
technique (TeSeE WB kit – BioRad, anti-PrP Sha31 antibody).
After extraction (25 mg of brain equivalent material) the re-
suspended pellet was entirely loaded on gels. (A) case 1: cerebral
cortex. (B) case 8: cerebellum. The same classical scrapie control
than in Figure 3A-3C was included on the two gels to calibrate the
signal (Lane 1). (C) The same dilution series were tested using a
commercially available rapid TSE test (TeSeE Sheep and Goat -
BioRad) used for field TSE screening in small ruminants. Three
different aliquots of each dilution were independently tested. The
extractionswerecarried out.Resultsarepresented asthe mean+/2
SD corrected optical density values. The cut off value (0.162 OD–
dotted line) was established as the mean of four negative control
optical densities +0.150 OD. (#: case 1. n: Case 8).
Found at: doi:10.1371/journal.ppat.1001285.s001 (0.43 MB TIF)
Figure S2 PrP
Sc Western Blot profile and vacuolar lesion profile
in tg338 mice inoculated with various tissues from an Atypical/
Nor98 scrapie and classical scrapie affected sheep. (A) PrP
Sc
Western Blot profile. Lane 1: posterior brainstem from a PG127
classical scrapie affected sheep (case 12). Lane 2: brain from a 700
days old negative control tg338 mouse. Lane 3: cerebral cortex
from an AFRQ/AFRQ Atypical scrapie/Nor98 natural case (case
1). Lanes 4–7, brains from tg338 mice inoculated with various
tissues homogenates prepared from an AFRQ/ARQ Atypical
scrapie/Nor98 experimental case (case 8). Lane 4: cerebellum.
Lane 5: prescapular lymph node. Lane 6: brachial nerve. Lane
7: external ocular motor muscle. Lane 8: brain from a tg338
mouse inoculated from a PG127 classical scrapie affected sheep
(case 12). (B) PrP
Sc Western Blot profile. Lane 1: posterior
brainstem from a PG127 classical scrapie isolate sheep (case 12).
Lane 2: brain from a 700 days old negative control tg338 mouse.
Lanes 3–9: brains from tg338 mice inoculated with various tissues
homogenates prepared from two VRQ/VRQ PG127 classical
scrapie cases (case 12 and 13). Lane 3: case 12, posterior
brainstem. Lane 4: case 12, ileal lymph node. Lane 5: case 12,
external ocular muscle. Lane 6: case 12, psoas muscle. Lane 7:
case 13, posterior brainstem. Lane 8: case 13, tonsil. Lane 9: case
13, external ocular motor muscle. Lane 10: posterior brainstem
from a PG127 classical scrapie sheep (case 12). (C–D) Lesion
profile (vacuolar changes) in tg338 mice inoculated with homog-
enates prepared from different tissues (C) an experimental
Atypical/Nor98 AFRQ/ARQ scrapie case (case 8) or (D)a n
Atypical/Nor98 Scrapie Detection
PLoS Pathogens | www.plospathogens.org 12 February 2011 | Volume 7 | Issue 2 | e1001285experimental VRQ/VRQ PG127 classical scrapie experimental
case (case 12). (C) # cerebellum X: brachial nerve, ,: external
ocular motor muscle. (D)N: posterior brainstem, ,: ileal lymph
node, #: external ocular motor muscle.
Found at: doi:10.1371/journal.ppat.1001285.s002 (0.53 MB TIF)
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